Literature DB >> 16188853

Human torovirus: a new virus associated with neonatal necrotizing enterocolitis.

Abhay Lodha1, Nicole de Silva, Martin Petric, Aideen M Moore.   

Abstract

AIM: Toroviruses have been associated with gastroenteritis in both animals and humans. The aim of this study was to examine the fecal excretion of torovirus in infants with necrotizing enterocolitis (NEC).
METHODS: We reviewed all infants with NEC admitted to our tertiary care NICU over a 5-y period who had stool specimens sent for microbial culture and virology. Infants in the NICU during the same period with diagnoses other than NEC served as controls.
RESULTS: Forty-four infants with NEC stages I-III were identified, and pathogenic organisms were identified in 27 (61%). Toroviruses were identified in stool cultures in 48% of patients with NEC, and 17% of the non-NEC controls (p<0.001). There was no significant difference in illness severity or mortality between the torovirus-positive and -negative infants with NEC.
CONCLUSION: Torovirus should be added to the list of infectious agents associated with NEC in newborn infants. The exact role torovirus plays in the etiology and progression of NEC warrants further investigation.

Entities:  

Mesh:

Year:  2005        PMID: 16188853     DOI: 10.1111/j.1651-2227.2005.tb02049.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  22 in total

1.  Temporal and seasonal variations in incidence of stage II and III NEC-a 28-year epidemiologic study from tertiary NICUs in Connecticut, USA.

Authors:  Darius Javidi; Zigeng Wang; Sanguthevar Rajasekaran; Naveed Hussain
Journal:  J Perinatol       Date:  2021-02-15       Impact factor: 2.521

2.  The association between enteric viruses and necrotizing enterocolitis.

Authors:  Chen Cheng; Yu He; Sa Xiao; Qing Ai; Jialin Yu
Journal:  Eur J Pediatr       Date:  2020-07-22       Impact factor: 3.183

3.  Clinical characteristics of viral intestinal infection in preterm and term neonates.

Authors:  S Bagci; A M Eis-Hübinger; A F Yassin; A Simon; P Bartmann; A R Franz; A Mueller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-20       Impact factor: 3.267

4.  First isolation of cytopathogenic bovine torovirus in cell culture from a calf with diarrhea.

Authors:  Masaki Kuwabara; Kazumasa Wada; Yukiko Maeda; Ayako Miyazaki; Hiroshi Tsunemitsu
Journal:  Clin Vaccine Immunol       Date:  2007-06-13

5.  Etiological role of viruses in outbreaks of acute gastroenteritis in The Netherlands from 1994 through 2005.

Authors:  Sanela Svraka; Erwin Duizer; Harry Vennema; Erwin de Bruin; Bas van der Veer; Bram Dorresteijn; Marion Koopmans
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

6.  The role of torovirus in nosocomial viral gastroenteritis at a large tertiary pediatric centre.

Authors:  Jb Gubbay; A Al-Rezqi; M Hawkes; L Williams; Se Richardson; A Matlow
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

7.  Mapping the New World of Necrotizing Enterocolitis (NEC): Review and Opinion.

Authors:  Phillip Gordon; Robert Christensen; Jörn-Hendrik Weitkamp; Akhil Maheshwari
Journal:  EJ Neonatol Res       Date:  2012

8.  The viral dsRNA analogue poly (I:C) induces necrotizing enterocolitis in neonatal mice.

Authors:  Marco Ginzel; Yi Yu; Christian Klemann; Xiaoyan Feng; Reinhard von Wasielewski; Joon-Keun Park; Mathias W Hornef; Natalia Torow; Gertrud Vieten; Benno M Ure; Joachim F Kuebler; Martin Lacher
Journal:  Pediatr Res       Date:  2015-12-17       Impact factor: 3.756

Review 9.  A clinical perspective of necrotizing enterocolitis: past, present, and future.

Authors:  Renu Sharma; Mark Lawrence Hudak
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

Review 10.  The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis.

Authors:  Anatoly Grishin; Stephanie Papillon; Brandon Bell; Jin Wang; Henri R Ford
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.